Clinicopathological Significance of Human Macrophage Metalloelastase Expression in Esophageal Squamous Cell Carcinoma
暂无分享,去创建一个
Yutaka Shimada | Masayuki Imamura | Atsushi Kawabe | Masato Maeda | M. Imamura | Y. Shimada | Atsushi Itami | A. Itami | Yongzeng Ding | Manuel J. Gorrin-Rivas | Zhigang Li | Tao Hong | Izumi Komoto | Junichi Kaganoi | J. Kaganoi | M. Gorrín-Rivas | M. Maeda | I. Komoto | A. Kawabe | Y. Ding | T. Hong | Zhigang Li | Yongzeng Ding
[1] R. Béliveau,et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors , 2004, Clinical & Experimental Metastasis.
[2] B. Nordlinger,et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] M. Mizumoto,et al. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] R. Pierce,et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.
[5] K. Sugimachi,et al. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] S. Arii,et al. Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance , 2001, Cancer.
[7] V. Kähäri,et al. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. , 1999, Annals of medicine.
[8] T. Ley,et al. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Isono,et al. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. , 1991, Oncology.
[10] Y. Sasaguri,et al. Production onf matrix metalloproteinase‐2 and metalloproteinase‐3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study , 1992, Cancer.
[11] M. Mizumoto,et al. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance , 1998, Hepatology.
[12] S. Shapiro,et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. , 2000, The Journal of investigative dermatology.
[13] S. Chandler,et al. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.
[14] K. Mimori,et al. Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.
[15] M. Imamura,et al. Characterization of 21 newly established esophageal cancer cell lines , 1992, Cancer.
[16] K. Sugimachi,et al. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma , 1988, The British journal of surgery.
[17] L. Matrisian,et al. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis , 1995, Cancer and Metastasis Reviews.
[18] S. Kitano,et al. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness , 2000, Gut.
[19] A. Hanby,et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.
[20] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[21] Z. Werb,et al. Mouse macrophage elastase. Purification and characterization as a metalloproteinase. , 1981, The Biochemical journal.
[22] I. Fidler,et al. Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung Carcinoma , 1997, Cell.
[23] M. Karjalainen‐Lindsberg,et al. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma , 2001, British Journal of Cancer.
[24] M. Dardenne. Role of thymic peptides as transmitters between the neuroendocrine and immune systems. , 1999, Annals of medicine.
[25] D. Carter. TNM Classification of Malignant Tumors , 1998 .